Vir Biotechnology to Participate in the Guggenheim 2nd Annual Vaccine & Infectious Disease Day ConferenceGlobeNewsWire • 09/30/21
Week 37 MDA Breakout Stocks - September 2021: Short-Term Picks To Give You An EdgeSeeking Alpha • 09/13/21
Vir Biotechnology to Participate in the Morgan Stanley 19th Annual Global Healthcare ConferenceGlobeNewsWire • 09/08/21
Vir Biotechnology to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/07/21
Vir Biotechnology Announces First Marketing Authorization for its First Commercial Product, Sotrovimab, Granted in AustraliaGlobeNewsWire • 08/23/21
Vir Biotechnology, Inc. (VIR) Q2 Earnings and Revenues Beat EstimatesZacks Investment Research • 08/05/21
Earnings Preview: Vir Biotechnology, Inc. (VIR) Q2 Earnings Expected to DeclineZacks Investment Research • 07/29/21
GSK and Vir Biotechnology Announce Joint Procurement Agreement with European Commission for COVID-19 Treatment, SotrovimabGlobeNewsWire • 07/28/21
Vir Biotechnology to Provide Corporate Update and Report Second Quarter 2021 Financial Results on August 5, 2021GlobeNewsWire • 07/22/21
Vir Biotechnology Starts Dosing In Mid-Stage Hepatitis B Trial With Combination TherapyBenzinga • 07/15/21
These COVID Therapies Appear to Be the Best and Worst at Treating New VariantsThe Motley Fool • 07/03/21
GlaxoSmithKline's and Vir's Latest COVID Therapy Results: What Investors Should KnowThe Motley Fool • 07/01/21
Vir's 'sock gains on early results from clinical trials for its hepatitis B treatment candidateMarket Watch • 06/25/21